Parthak Prodhan
Concepts (436)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Extracorporeal Membrane Oxygenation | 32 | 2021 | 287 | 7.500 |
Why?
| Hypoplastic Left Heart Syndrome | 5 | 2018 | 97 | 2.690 |
Why?
| Infant | 56 | 2024 | 3551 | 2.520 |
Why?
| Hospital Mortality | 18 | 2024 | 413 | 2.420 |
Why?
| Infant, Newborn | 48 | 2024 | 2744 | 2.400 |
Why?
| Norwood Procedures | 5 | 2022 | 56 | 2.300 |
Why?
| Heart Defects, Congenital | 10 | 2024 | 592 | 2.180 |
Why?
| Heart-Assist Devices | 8 | 2016 | 147 | 2.020 |
Why?
| Child, Preschool | 47 | 2024 | 3853 | 1.930 |
Why?
| Palliative Care | 6 | 2020 | 187 | 1.910 |
Why?
| Respiration, Artificial | 8 | 2015 | 265 | 1.860 |
Why?
| Retrospective Studies | 51 | 2024 | 6117 | 1.850 |
Why?
| Heart Diseases | 7 | 2021 | 208 | 1.770 |
Why?
| Child | 53 | 2022 | 6824 | 1.600 |
Why?
| Heart Failure | 6 | 2022 | 454 | 1.520 |
Why?
| Length of Stay | 12 | 2024 | 623 | 1.510 |
Why?
| Hemolytic-Uremic Syndrome | 2 | 2021 | 15 | 1.510 |
Why?
| Cardiopulmonary Resuscitation | 5 | 2019 | 133 | 1.440 |
Why?
| Male | 66 | 2024 | 25093 | 1.390 |
Why?
| Heart Transplantation | 9 | 2018 | 312 | 1.330 |
Why?
| Tetralogy of Fallot | 7 | 2021 | 86 | 1.330 |
Why?
| Humans | 101 | 2024 | 49827 | 1.320 |
Why?
| Female | 68 | 2024 | 26329 | 1.290 |
Why?
| Registries | 10 | 2019 | 518 | 1.220 |
Why?
| Intensive Care Units, Pediatric | 9 | 2022 | 168 | 1.160 |
Why?
| Risk Factors | 21 | 2024 | 3619 | 1.100 |
Why?
| Terminal Care | 2 | 2020 | 45 | 1.100 |
Why?
| Cardiac Surgical Procedures | 9 | 2022 | 298 | 1.080 |
Why?
| Adolescent | 29 | 2021 | 6340 | 1.040 |
Why?
| Down Syndrome | 4 | 2021 | 91 | 0.910 |
Why?
| Cohort Studies | 10 | 2021 | 1422 | 0.890 |
Why?
| Treatment Outcome | 23 | 2021 | 5138 | 0.820 |
Why?
| Adenovirus Infections, Human | 3 | 2024 | 7 | 0.810 |
Why?
| Systemic Inflammatory Response Syndrome | 3 | 2021 | 54 | 0.790 |
Why?
| Respiratory Insufficiency | 3 | 2014 | 112 | 0.780 |
Why?
| Hospitalization | 9 | 2024 | 653 | 0.780 |
Why?
| Pulmonary Artery | 1 | 2022 | 145 | 0.760 |
Why?
| Heart Arrest | 4 | 2022 | 148 | 0.740 |
Why?
| Brain Diseases | 1 | 2021 | 82 | 0.720 |
Why?
| Hospice Care | 1 | 2020 | 27 | 0.710 |
Why?
| Patient Transfer | 5 | 2015 | 95 | 0.700 |
Why?
| Gastrostomy | 3 | 2020 | 55 | 0.700 |
Why?
| American Heart Association | 1 | 2019 | 32 | 0.690 |
Why?
| Critical Care | 5 | 2020 | 201 | 0.690 |
Why?
| Monitoring, Physiologic | 3 | 2016 | 121 | 0.690 |
Why?
| Respiratory Distress Syndrome, Newborn | 2 | 2014 | 52 | 0.680 |
Why?
| Critical Illness | 7 | 2022 | 286 | 0.680 |
Why?
| Respiratory Syncytial Virus Infections | 2 | 2010 | 36 | 0.670 |
Why?
| Home Care Services | 1 | 2020 | 73 | 0.660 |
Why?
| Cardiopulmonary Bypass | 5 | 2013 | 91 | 0.660 |
Why?
| Follow-Up Studies | 10 | 2018 | 2179 | 0.640 |
Why?
| Oxygen | 3 | 2014 | 325 | 0.630 |
Why?
| Tracheostomy | 3 | 2020 | 75 | 0.610 |
Why?
| Enteral Nutrition | 2 | 2018 | 146 | 0.600 |
Why?
| Enterocolitis, Necrotizing | 1 | 2018 | 35 | 0.600 |
Why?
| Chromosome Disorders | 1 | 2017 | 35 | 0.580 |
Why?
| Heart Bypass, Right | 1 | 2017 | 7 | 0.580 |
Why?
| Time Factors | 14 | 2021 | 2912 | 0.580 |
Why?
| Patient Discharge | 4 | 2013 | 322 | 0.540 |
Why?
| Adrenal Cortex Hormones | 2 | 2015 | 93 | 0.530 |
Why?
| Pressure | 1 | 2016 | 102 | 0.520 |
Why?
| Airway Extubation | 2 | 2012 | 30 | 0.520 |
Why?
| Shock, Septic | 3 | 2011 | 78 | 0.510 |
Why?
| Chromosomes, Human, Pair 22 | 1 | 2015 | 39 | 0.500 |
Why?
| Transportation of Patients | 2 | 2012 | 37 | 0.500 |
Why?
| Acute-Phase Proteins | 1 | 2015 | 24 | 0.500 |
Why?
| Stenotrophomonas maltophilia | 1 | 2014 | 6 | 0.490 |
Why?
| Databases, Factual | 5 | 2018 | 664 | 0.490 |
Why?
| Gram-Negative Bacterial Infections | 1 | 2014 | 41 | 0.480 |
Why?
| Intensive Care Units, Neonatal | 2 | 2012 | 110 | 0.480 |
Why?
| von Willebrand Factor | 1 | 2014 | 42 | 0.480 |
Why?
| Chromosome Deletion | 1 | 2015 | 141 | 0.470 |
Why?
| von Willebrand Diseases | 1 | 2014 | 22 | 0.470 |
Why?
| Postoperative Hemorrhage | 1 | 2014 | 52 | 0.470 |
Why?
| Respiratory Tract Fistula | 1 | 2013 | 2 | 0.470 |
Why?
| Bronchial Fistula | 1 | 2013 | 4 | 0.460 |
Why?
| Phosphodiesterase 5 Inhibitors | 1 | 2013 | 7 | 0.460 |
Why?
| Sulfones | 1 | 2013 | 24 | 0.460 |
Why?
| Catheters | 2 | 2013 | 31 | 0.460 |
Why?
| Pleural Diseases | 1 | 2013 | 15 | 0.460 |
Why?
| Off-Label Use | 1 | 2013 | 25 | 0.460 |
Why?
| Oxygen Consumption | 2 | 2012 | 180 | 0.450 |
Why?
| Survival Rate | 6 | 2018 | 905 | 0.450 |
Why?
| Drug Utilization | 1 | 2013 | 78 | 0.440 |
Why?
| Cause of Death | 1 | 2014 | 145 | 0.440 |
Why?
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2013 | 22 | 0.440 |
Why?
| Air Ambulances | 2 | 2012 | 24 | 0.430 |
Why?
| Pneumothorax | 1 | 2013 | 21 | 0.430 |
Why?
| Piperazines | 1 | 2013 | 117 | 0.430 |
Why?
| Coronary Care Units | 1 | 2012 | 8 | 0.420 |
Why?
| Hemodynamics | 2 | 2011 | 229 | 0.420 |
Why?
| Positive-Pressure Respiration | 1 | 2013 | 57 | 0.420 |
Why?
| Postoperative Complications | 5 | 2022 | 1000 | 0.420 |
Why?
| Altitude | 1 | 2012 | 16 | 0.410 |
Why?
| Intra-Abdominal Hypertension | 1 | 2012 | 6 | 0.410 |
Why?
| Jugular Veins | 1 | 2012 | 31 | 0.410 |
Why?
| Hepacivirus | 1 | 2013 | 103 | 0.410 |
Why?
| Sepsis | 2 | 2018 | 220 | 0.410 |
Why?
| Femoral Vein | 1 | 2012 | 40 | 0.410 |
Why?
| Renal Artery | 1 | 2012 | 33 | 0.410 |
Why?
| Carotid Arteries | 1 | 2012 | 85 | 0.410 |
Why?
| Hepatitis C, Chronic | 1 | 2013 | 82 | 0.410 |
Why?
| Renal Circulation | 1 | 2012 | 59 | 0.400 |
Why?
| Heart Block | 1 | 2012 | 26 | 0.400 |
Why?
| Hypertension, Pulmonary | 1 | 2013 | 114 | 0.400 |
Why?
| Career Choice | 1 | 2013 | 111 | 0.400 |
Why?
| Emergencies | 1 | 2012 | 87 | 0.400 |
Why?
| Continuity of Patient Care | 1 | 2012 | 53 | 0.400 |
Why?
| Echocardiography, Doppler | 1 | 2012 | 52 | 0.400 |
Why?
| Echocardiography, Transesophageal | 1 | 2012 | 60 | 0.400 |
Why?
| Radiography, Thoracic | 3 | 2011 | 66 | 0.390 |
Why?
| Neutropenia | 1 | 2012 | 117 | 0.390 |
Why?
| Kidney Failure, Chronic | 1 | 2013 | 197 | 0.390 |
Why?
| Abnormalities, Multiple | 1 | 2013 | 167 | 0.390 |
Why?
| Femoral Artery | 1 | 2012 | 100 | 0.390 |
Why?
| Intensive Care Units | 4 | 2014 | 210 | 0.380 |
Why?
| Arrhythmias, Cardiac | 1 | 2012 | 93 | 0.380 |
Why?
| Arkansas | 8 | 2012 | 1967 | 0.380 |
Why?
| DiGeorge Syndrome | 2 | 2021 | 20 | 0.380 |
Why?
| Quality of Health Care | 1 | 2012 | 185 | 0.370 |
Why?
| Adrenal Insufficiency | 1 | 2010 | 18 | 0.370 |
Why?
| Survival Analysis | 5 | 2017 | 659 | 0.360 |
Why?
| Herpesviridae Infections | 1 | 2010 | 46 | 0.360 |
Why?
| Young Adult | 9 | 2017 | 3936 | 0.350 |
Why?
| Respiratory Sounds | 2 | 2011 | 47 | 0.340 |
Why?
| Blood Specimen Collection | 1 | 2009 | 34 | 0.340 |
Why?
| Expectorants | 1 | 2009 | 14 | 0.340 |
Why?
| Pulmonary Atelectasis | 1 | 2009 | 11 | 0.340 |
Why?
| Troponin I | 1 | 2009 | 18 | 0.340 |
Why?
| Wounds and Injuries | 1 | 2012 | 284 | 0.340 |
Why?
| Deoxyribonucleases | 1 | 2009 | 23 | 0.330 |
Why?
| Cardiac Catheterization | 4 | 2019 | 196 | 0.330 |
Why?
| Thoracic Injuries | 2 | 2013 | 35 | 0.330 |
Why?
| Kidney | 1 | 2013 | 665 | 0.330 |
Why?
| Acute Kidney Injury | 1 | 2012 | 283 | 0.330 |
Why?
| Diagnostic Techniques, Respiratory System | 1 | 2008 | 1 | 0.330 |
Why?
| Prospective Studies | 7 | 2022 | 2344 | 0.320 |
Why?
| Anti-Bacterial Agents | 1 | 2014 | 743 | 0.320 |
Why?
| Therapy, Computer-Assisted | 1 | 2008 | 30 | 0.320 |
Why?
| Altitude Sickness | 2 | 2012 | 7 | 0.320 |
Why?
| Diagnosis, Computer-Assisted | 1 | 2008 | 48 | 0.320 |
Why?
| Respiratory Therapy | 1 | 2008 | 34 | 0.310 |
Why?
| Nurses | 1 | 2008 | 48 | 0.310 |
Why?
| Image Interpretation, Computer-Assisted | 1 | 2008 | 105 | 0.310 |
Why?
| Risk Assessment | 5 | 2017 | 1262 | 0.300 |
Why?
| Decision Making | 1 | 2010 | 262 | 0.300 |
Why?
| Compartment Syndromes | 2 | 2007 | 16 | 0.300 |
Why?
| Internship and Residency | 1 | 2013 | 446 | 0.290 |
Why?
| Lung | 4 | 2022 | 480 | 0.290 |
Why?
| Prognosis | 5 | 2012 | 1952 | 0.280 |
Why?
| Hospitals, Pediatric | 5 | 2015 | 239 | 0.260 |
Why?
| Case-Control Studies | 4 | 2019 | 1128 | 0.260 |
Why?
| Brain | 3 | 2012 | 1309 | 0.260 |
Why?
| United States | 6 | 2019 | 4838 | 0.250 |
Why?
| Physicians | 1 | 2008 | 234 | 0.250 |
Why?
| Algorithms | 1 | 2008 | 616 | 0.250 |
Why?
| Noninvasive Ventilation | 2 | 2017 | 21 | 0.250 |
Why?
| Heparin | 3 | 2014 | 92 | 0.250 |
Why?
| Schistosomiasis haematobia | 1 | 2004 | 2 | 0.240 |
Why?
| Mitral Valve Insufficiency | 2 | 2015 | 44 | 0.240 |
Why?
| Urinary Bladder Diseases | 1 | 2004 | 18 | 0.240 |
Why?
| Hematuria | 1 | 2004 | 26 | 0.230 |
Why?
| Logistic Models | 5 | 2021 | 891 | 0.230 |
Why?
| Severity of Illness Index | 5 | 2021 | 942 | 0.230 |
Why?
| Odds Ratio | 4 | 2021 | 548 | 0.230 |
Why?
| Chylothorax | 2 | 2022 | 15 | 0.230 |
Why?
| Kaplan-Meier Estimate | 3 | 2019 | 469 | 0.230 |
Why?
| Retinal Hemorrhage | 1 | 2003 | 14 | 0.230 |
Why?
| Asphyxia | 1 | 2003 | 9 | 0.230 |
Why?
| Orbital Diseases | 1 | 2003 | 14 | 0.220 |
Why?
| Encephalocele | 1 | 2003 | 12 | 0.220 |
Why?
| Syndrome | 2 | 2015 | 234 | 0.220 |
Why?
| Neck Injuries | 1 | 2003 | 21 | 0.220 |
Why?
| ROC Curve | 4 | 2012 | 232 | 0.220 |
Why?
| Water-Electrolyte Imbalance | 1 | 2022 | 15 | 0.210 |
Why?
| Pulmonary Edema | 1 | 2002 | 19 | 0.210 |
Why?
| Accidents, Traffic | 1 | 2003 | 87 | 0.210 |
Why?
| Anticoagulants | 3 | 2014 | 254 | 0.210 |
Why?
| Pilot Projects | 3 | 2014 | 699 | 0.210 |
Why?
| Reoperation | 3 | 2014 | 452 | 0.210 |
Why?
| Program Evaluation | 3 | 2018 | 349 | 0.200 |
Why?
| Pediatrics | 2 | 2008 | 277 | 0.200 |
Why?
| Neoplasms | 1 | 2012 | 1233 | 0.200 |
Why?
| Incidence | 3 | 2014 | 1003 | 0.200 |
Why?
| Reproducibility of Results | 3 | 2010 | 1188 | 0.190 |
Why?
| Hypoxia, Brain | 1 | 2021 | 15 | 0.190 |
Why?
| Delivery of Health Care | 1 | 2004 | 307 | 0.190 |
Why?
| Cerebrovascular Circulation | 3 | 2014 | 131 | 0.190 |
Why?
| Body Weight | 2 | 2014 | 513 | 0.190 |
Why?
| North America | 1 | 2021 | 66 | 0.190 |
Why?
| Health Information Systems | 1 | 2021 | 20 | 0.190 |
Why?
| Cerebral Infarction | 1 | 2021 | 39 | 0.190 |
Why?
| Pneumonia, Viral | 1 | 2024 | 168 | 0.190 |
Why?
| Gestational Age | 2 | 2013 | 417 | 0.190 |
Why?
| Heart Septal Defects, Atrial | 2 | 2012 | 44 | 0.190 |
Why?
| Confidence Intervals | 1 | 2021 | 156 | 0.190 |
Why?
| Aortic Coarctation | 1 | 2021 | 31 | 0.190 |
Why?
| Brain Edema | 1 | 2021 | 41 | 0.180 |
Why?
| Terminally Ill | 1 | 2020 | 14 | 0.180 |
Why?
| Catheter-Related Infections | 1 | 2020 | 50 | 0.180 |
Why?
| Central Venous Catheters | 1 | 2020 | 27 | 0.180 |
Why?
| Spectroscopy, Near-Infrared | 4 | 2014 | 53 | 0.180 |
Why?
| Predictive Value of Tests | 3 | 2012 | 904 | 0.180 |
Why?
| Cerebral Hemorrhage | 1 | 2021 | 104 | 0.180 |
Why?
| Postoperative Period | 5 | 2022 | 172 | 0.180 |
Why?
| Catheterization, Central Venous | 1 | 2020 | 87 | 0.170 |
Why?
| Platelet Membrane Glycoproteins | 1 | 2018 | 18 | 0.160 |
Why?
| Cell-Derived Microparticles | 1 | 2018 | 20 | 0.160 |
Why?
| C-Reactive Protein | 3 | 2015 | 142 | 0.160 |
Why?
| Smoking | 1 | 2002 | 510 | 0.160 |
Why?
| Haplotypes | 1 | 2018 | 83 | 0.160 |
Why?
| Aged, 80 and over | 3 | 2017 | 3125 | 0.160 |
Why?
| Infant Mortality | 1 | 2018 | 61 | 0.150 |
Why?
| Birth Weight | 1 | 2018 | 120 | 0.150 |
Why?
| Academic Medical Centers | 1 | 2018 | 132 | 0.150 |
Why?
| Perioperative Care | 1 | 2017 | 42 | 0.150 |
Why?
| Faculty, Medical | 1 | 2018 | 90 | 0.140 |
Why?
| Hospitals | 3 | 2022 | 175 | 0.140 |
Why?
| Shock, Cardiogenic | 1 | 2017 | 25 | 0.140 |
Why?
| Inflammation | 3 | 2012 | 604 | 0.140 |
Why?
| Whole Blood Coagulation Time | 2 | 2014 | 6 | 0.140 |
Why?
| Waiting Lists | 1 | 2016 | 50 | 0.140 |
Why?
| Blood Platelets | 1 | 2018 | 245 | 0.140 |
Why?
| Ultrasonography | 2 | 2022 | 436 | 0.140 |
Why?
| Chromosome Aberrations | 1 | 2017 | 298 | 0.130 |
Why?
| Signal Transduction | 1 | 2002 | 1617 | 0.130 |
Why?
| Patient Selection | 1 | 2016 | 251 | 0.130 |
Why?
| Drug Administration Schedule | 3 | 2012 | 376 | 0.130 |
Why?
| Cardiomyopathy, Dilated | 1 | 2015 | 36 | 0.130 |
Why?
| Fibrinogen | 1 | 2015 | 31 | 0.130 |
Why?
| Patient Care Planning | 1 | 2015 | 67 | 0.120 |
Why?
| Clavulanic Acids | 1 | 2014 | 8 | 0.120 |
Why?
| Ticarcillin | 1 | 2014 | 8 | 0.120 |
Why?
| Resuscitation | 1 | 2015 | 76 | 0.120 |
Why?
| Nerve Growth Factors | 2 | 2005 | 27 | 0.120 |
Why?
| Erythrocyte Transfusion | 1 | 2014 | 46 | 0.120 |
Why?
| Sternotomy | 1 | 2014 | 8 | 0.120 |
Why?
| Heart Septal Defects | 1 | 2014 | 11 | 0.120 |
Why?
| Factor Xa | 1 | 2014 | 7 | 0.120 |
Why?
| Disease Progression | 2 | 2018 | 822 | 0.120 |
Why?
| Healthcare Disparities | 1 | 2017 | 258 | 0.120 |
Why?
| Peritoneal Dialysis | 2 | 2012 | 33 | 0.120 |
Why?
| Autopsy | 1 | 2014 | 46 | 0.120 |
Why?
| Antithrombin III | 1 | 2014 | 12 | 0.120 |
Why?
| Adrenal Glands | 1 | 2014 | 39 | 0.120 |
Why?
| Blood Coagulation Disorders | 1 | 2014 | 33 | 0.120 |
Why?
| Antithrombins | 1 | 2014 | 19 | 0.120 |
Why?
| Tumor Suppressor Proteins | 2 | 2005 | 127 | 0.110 |
Why?
| Age Factors | 3 | 2017 | 1090 | 0.110 |
Why?
| Leukemia, Myeloid, Acute | 1 | 2015 | 183 | 0.110 |
Why?
| Purines | 1 | 2013 | 38 | 0.110 |
Why?
| Aged | 4 | 2017 | 9272 | 0.110 |
Why?
| Adult | 5 | 2022 | 13160 | 0.110 |
Why?
| Heparin Antagonists | 1 | 2013 | 7 | 0.110 |
Why?
| Protamines | 1 | 2013 | 8 | 0.110 |
Why?
| Hernia, Diaphragmatic | 1 | 2013 | 22 | 0.110 |
Why?
| Thrombelastography | 1 | 2013 | 26 | 0.110 |
Why?
| Comorbidity | 2 | 2014 | 618 | 0.100 |
Why?
| Interleukin-3 | 1 | 2012 | 13 | 0.100 |
Why?
| Organizational Objectives | 1 | 2012 | 33 | 0.100 |
Why?
| Calcitonin Gene-Related Peptide | 1 | 2012 | 22 | 0.100 |
Why?
| Hip | 1 | 2012 | 25 | 0.100 |
Why?
| Protein Precursors | 1 | 2012 | 43 | 0.100 |
Why?
| Aircraft | 1 | 2012 | 9 | 0.100 |
Why?
| Calcitonin | 1 | 2012 | 30 | 0.100 |
Why?
| Pulsatile Flow | 1 | 2012 | 19 | 0.100 |
Why?
| Rotation | 1 | 2012 | 45 | 0.100 |
Why?
| Hemorrhage | 1 | 2014 | 202 | 0.100 |
Why?
| Professional-Family Relations | 1 | 2012 | 44 | 0.100 |
Why?
| Models, Organizational | 1 | 2012 | 59 | 0.100 |
Why?
| Treatment Failure | 1 | 2012 | 113 | 0.100 |
Why?
| Interdisciplinary Communication | 1 | 2012 | 55 | 0.100 |
Why?
| Patient Positioning | 1 | 2012 | 32 | 0.100 |
Why?
| Vascular Resistance | 1 | 2012 | 54 | 0.100 |
Why?
| Tertiary Care Centers | 1 | 2012 | 77 | 0.100 |
Why?
| Premedication | 1 | 2011 | 21 | 0.100 |
Why?
| Interleukin-8 | 1 | 2012 | 87 | 0.100 |
Why?
| Fluconazole | 1 | 2011 | 34 | 0.100 |
Why?
| Septal Occluder Device | 1 | 2012 | 26 | 0.100 |
Why?
| Body Height | 1 | 2012 | 65 | 0.100 |
Why?
| Blood Flow Velocity | 1 | 2012 | 99 | 0.100 |
Why?
| Regional Blood Flow | 1 | 2012 | 108 | 0.100 |
Why?
| Interleukin-10 | 1 | 2012 | 84 | 0.100 |
Why?
| Heart Septal Defects, Ventricular | 1 | 2012 | 43 | 0.100 |
Why?
| Health Care Surveys | 1 | 2012 | 174 | 0.100 |
Why?
| Ketamine | 1 | 2012 | 60 | 0.100 |
Why?
| Infarction, Middle Cerebral Artery | 1 | 2011 | 40 | 0.100 |
Why?
| Hemolysis | 1 | 2011 | 27 | 0.100 |
Why?
| Azygos Vein | 1 | 2011 | 11 | 0.100 |
Why?
| Combined Modality Therapy | 1 | 2013 | 636 | 0.100 |
Why?
| Tomography, X-Ray Computed | 2 | 2010 | 1159 | 0.100 |
Why?
| Neuroprotective Agents | 1 | 2012 | 105 | 0.100 |
Why?
| Thrombosis | 1 | 2014 | 249 | 0.100 |
Why?
| Cross Infection | 1 | 2011 | 95 | 0.090 |
Why?
| Aortic Stenosis, Supravalvular | 1 | 2010 | 11 | 0.090 |
Why?
| Comprehension | 1 | 2012 | 110 | 0.090 |
Why?
| Adrenal Cortex Function Tests | 1 | 2010 | 5 | 0.090 |
Why?
| Respiratory Tract Infections | 1 | 2011 | 75 | 0.090 |
Why?
| Tissue Plasminogen Activator | 1 | 2011 | 110 | 0.090 |
Why?
| Thrombolytic Therapy | 1 | 2011 | 111 | 0.090 |
Why?
| Anti-Inflammatory Agents | 1 | 2012 | 162 | 0.090 |
Why?
| Fibrinolytic Agents | 1 | 2011 | 125 | 0.090 |
Why?
| Adrenocorticotropic Hormone | 1 | 2010 | 31 | 0.090 |
Why?
| Interleukin-6 | 1 | 2012 | 264 | 0.090 |
Why?
| Catheterization | 2 | 2011 | 97 | 0.090 |
Why?
| Mycoses | 1 | 2011 | 158 | 0.090 |
Why?
| Brain Injuries | 1 | 2012 | 160 | 0.090 |
Why?
| Echocardiography | 2 | 2011 | 378 | 0.090 |
Why?
| Patient Care Team | 1 | 2012 | 255 | 0.090 |
Why?
| Boston | 1 | 2010 | 12 | 0.090 |
Why?
| Feasibility Studies | 1 | 2012 | 374 | 0.090 |
Why?
| Hydrocortisone | 1 | 2010 | 107 | 0.090 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2012 | 388 | 0.090 |
Why?
| Myocardial Infarction | 1 | 2014 | 382 | 0.090 |
Why?
| Diagnosis, Differential | 2 | 2004 | 1036 | 0.090 |
Why?
| Lactates | 1 | 2010 | 29 | 0.090 |
Why?
| Inpatients | 1 | 2011 | 189 | 0.090 |
Why?
| Nutritional Support | 1 | 2010 | 34 | 0.090 |
Why?
| Regression Analysis | 4 | 2013 | 395 | 0.090 |
Why?
| Chronic Disease | 1 | 2012 | 563 | 0.090 |
Why?
| Lymphopenia | 1 | 2009 | 18 | 0.090 |
Why?
| Heart Valve Prosthesis Implantation | 1 | 2010 | 80 | 0.090 |
Why?
| Pulmonary Gas Exchange | 1 | 2009 | 20 | 0.080 |
Why?
| Pulmonary Ventilation | 1 | 2009 | 11 | 0.080 |
Why?
| Infant, Premature | 1 | 2012 | 308 | 0.080 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 987 | 0.080 |
Why?
| Nutritional Status | 1 | 2010 | 140 | 0.080 |
Why?
| Alanine Transaminase | 1 | 2009 | 124 | 0.080 |
Why?
| Substance Withdrawal Syndrome | 1 | 2010 | 168 | 0.080 |
Why?
| Antifungal Agents | 1 | 2011 | 339 | 0.080 |
Why?
| Attitude of Health Personnel | 1 | 2012 | 348 | 0.080 |
Why?
| Lactic Acid | 1 | 2009 | 76 | 0.080 |
Why?
| Reference Values | 1 | 2009 | 310 | 0.080 |
Why?
| Analysis of Variance | 1 | 2010 | 565 | 0.080 |
Why?
| Endocarditis, Bacterial | 1 | 2009 | 44 | 0.080 |
Why?
| Neutrophils | 1 | 2009 | 137 | 0.080 |
Why?
| Stroke | 1 | 2013 | 492 | 0.080 |
Why?
| Sex Factors | 1 | 2010 | 693 | 0.080 |
Why?
| Recombinant Proteins | 1 | 2009 | 486 | 0.070 |
Why?
| Emergency Medical Services | 1 | 2008 | 111 | 0.070 |
Why?
| Pain | 1 | 2010 | 380 | 0.070 |
Why?
| Age of Onset | 2 | 2018 | 106 | 0.070 |
Why?
| Renal Dialysis | 2 | 2022 | 169 | 0.070 |
Why?
| Abdomen | 1 | 2007 | 79 | 0.070 |
Why?
| Sensitivity and Specificity | 1 | 2008 | 854 | 0.070 |
Why?
| Oximetry | 1 | 2007 | 66 | 0.070 |
Why?
| Receptors, Cell Surface | 2 | 2005 | 121 | 0.070 |
Why?
| Opioid-Related Disorders | 1 | 2010 | 375 | 0.070 |
Why?
| Cerebral Cortex | 1 | 2007 | 200 | 0.070 |
Why?
| Leukocytes | 1 | 2005 | 66 | 0.060 |
Why?
| Analgesics, Opioid | 1 | 2010 | 532 | 0.060 |
Why?
| Cell Movement | 1 | 2005 | 247 | 0.060 |
Why?
| Pulmonary Surfactants | 1 | 2004 | 18 | 0.060 |
Why?
| India | 1 | 2004 | 51 | 0.060 |
Why?
| Posture | 1 | 2004 | 59 | 0.060 |
Why?
| Vasodilator Agents | 1 | 2004 | 97 | 0.060 |
Why?
| Endothelial Cells | 1 | 2005 | 269 | 0.060 |
Why?
| Intracranial Pressure | 1 | 2003 | 31 | 0.060 |
Why?
| Drosophila Proteins | 1 | 2003 | 25 | 0.050 |
Why?
| Dialysis | 1 | 2022 | 8 | 0.050 |
Why?
| Cell Adhesion Molecules | 1 | 2003 | 85 | 0.050 |
Why?
| Receptors, Immunologic | 1 | 2003 | 37 | 0.050 |
Why?
| Platelet-Derived Growth Factor | 1 | 2002 | 23 | 0.050 |
Why?
| Morphogenesis | 1 | 2002 | 16 | 0.050 |
Why?
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2002 | 12 | 0.050 |
Why?
| Sternum | 1 | 2022 | 9 | 0.050 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2002 | 138 | 0.050 |
Why?
| Intubation, Intratracheal | 1 | 2003 | 118 | 0.050 |
Why?
| Vasodilation | 1 | 2002 | 97 | 0.050 |
Why?
| Surgical Wound Infection | 1 | 2022 | 117 | 0.050 |
Why?
| Nerve Tissue Proteins | 1 | 2003 | 193 | 0.050 |
Why?
| Nitric Oxide | 1 | 2002 | 253 | 0.050 |
Why?
| Equipment Design | 2 | 2011 | 282 | 0.050 |
Why?
| Chi-Square Distribution | 2 | 2011 | 282 | 0.040 |
Why?
| Staff Development | 1 | 2018 | 23 | 0.040 |
Why?
| Efficiency | 1 | 2018 | 32 | 0.040 |
Why?
| Genetic Association Studies | 1 | 2018 | 116 | 0.040 |
Why?
| Social Responsibility | 1 | 2018 | 26 | 0.040 |
Why?
| Gene Expression Profiling | 1 | 2003 | 1031 | 0.040 |
Why?
| Job Satisfaction | 1 | 2018 | 35 | 0.040 |
Why?
| Burnout, Professional | 1 | 2018 | 50 | 0.040 |
Why?
| Leadership | 1 | 2018 | 100 | 0.040 |
Why?
| Self Efficacy | 1 | 2018 | 128 | 0.040 |
Why?
| Age Distribution | 1 | 2017 | 170 | 0.040 |
Why?
| Communication | 1 | 2018 | 244 | 0.030 |
Why?
| Animals | 4 | 2005 | 13150 | 0.030 |
Why?
| Phenotype | 1 | 2018 | 727 | 0.030 |
Why?
| Genetic Predisposition to Disease | 1 | 2018 | 510 | 0.030 |
Why?
| Multiple Organ Failure | 1 | 2015 | 47 | 0.030 |
Why?
| National Institutes of Health (U.S.) | 1 | 2015 | 46 | 0.030 |
Why?
| Hematocrit | 1 | 2014 | 45 | 0.030 |
Why?
| Hospital Charges | 1 | 2014 | 43 | 0.030 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 595 | 0.030 |
Why?
| Case Management | 1 | 2013 | 43 | 0.030 |
Why?
| Intention to Treat Analysis | 1 | 2012 | 27 | 0.030 |
Why?
| Prosthesis Design | 1 | 2013 | 236 | 0.030 |
Why?
| Injections, Intravenous | 1 | 2012 | 140 | 0.030 |
Why?
| Centrifugation | 1 | 2011 | 14 | 0.030 |
Why?
| Gastroenteritis | 1 | 2011 | 17 | 0.020 |
Why?
| Central Nervous System | 1 | 2012 | 85 | 0.020 |
Why?
| Ductus Arteriosus | 1 | 2011 | 11 | 0.020 |
Why?
| Ambulances | 1 | 2011 | 7 | 0.020 |
Why?
| Linear Models | 1 | 2012 | 281 | 0.020 |
Why?
| Hemoglobins | 1 | 2011 | 108 | 0.020 |
Why?
| Blood Pressure Monitors | 1 | 2010 | 10 | 0.020 |
Why?
| Blood Pressure Determination | 1 | 2010 | 41 | 0.020 |
Why?
| Single-Blind Method | 1 | 2010 | 116 | 0.020 |
Why?
| Radiography | 1 | 2011 | 489 | 0.020 |
Why?
| Tachyphylaxis | 1 | 2010 | 2 | 0.020 |
Why?
| Receptors, Opioid | 1 | 2010 | 18 | 0.020 |
Why?
| Double-Blind Method | 1 | 2012 | 674 | 0.020 |
Why?
| Child Development | 1 | 2012 | 185 | 0.020 |
Why?
| Prealbumin | 1 | 2010 | 21 | 0.020 |
Why?
| Models, Statistical | 1 | 2011 | 225 | 0.020 |
Why?
| Cardiology | 1 | 2011 | 89 | 0.020 |
Why?
| Drug Tolerance | 1 | 2010 | 60 | 0.020 |
Why?
| Multivariate Analysis | 1 | 2011 | 585 | 0.020 |
Why?
| Nutritional Requirements | 1 | 2010 | 66 | 0.020 |
Why?
| Mice | 3 | 2005 | 5720 | 0.020 |
Why?
| Dose-Response Relationship, Drug | 1 | 2013 | 1374 | 0.020 |
Why?
| Anesthesia, General | 1 | 2010 | 87 | 0.020 |
Why?
| Cytokines | 1 | 2012 | 612 | 0.020 |
Why?
| Intraoperative Complications | 1 | 2010 | 119 | 0.020 |
Why?
| Emergency Service, Hospital | 1 | 2011 | 488 | 0.020 |
Why?
| Neurons | 1 | 2010 | 459 | 0.020 |
Why?
| Dietary Supplements | 1 | 2010 | 441 | 0.020 |
Why?
| Chemotaxis | 1 | 2005 | 23 | 0.020 |
Why?
| Superoxides | 1 | 2005 | 46 | 0.020 |
Why?
| DNA Primers | 1 | 2005 | 206 | 0.020 |
Why?
| Magnetic Resonance Imaging | 1 | 2012 | 1533 | 0.020 |
Why?
| Blotting, Western | 1 | 2005 | 602 | 0.010 |
Why?
| Pulmonary Surfactant-Associated Protein B | 1 | 2003 | 4 | 0.010 |
Why?
| Middle Aged | 1 | 2017 | 11997 | 0.010 |
Why?
| Cells, Cultured | 1 | 2005 | 1571 | 0.010 |
Why?
| Immunohistochemistry | 1 | 2003 | 971 | 0.010 |
Why?
| Mice, Inbred C57BL | 1 | 2005 | 1806 | 0.010 |
Why?
|
|
Prodhan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|